Skip to main content
GPCR
NASDAQ Life Sciences

Structure Therapeutics Posts $1.98/Share Q3 Loss, Nearly Triple the 58-Cent Consensus

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$20.95
Mkt Cap
$1.551B
52W Low
$18.7
52W High
$94.9
52W Position info
12% above low
Off High info
78% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

GPCR is trading near its 52-week low of $18.7 (12% above the low).

Summary

Structure Therapeutics reported a Q3 adjusted loss of $1.98 per share, far wider than the 58-cent loss fifteen analysts expected and outside the -$1.37 to -$0.36 range. The net loss was $144.76 million with zero revenue, as Phase 3 spending ramps. That follows the 8-K and 10-Q filed November 9, which disclosed the same $144.8M loss and $1.2B in cash said to fund operations through 2028 — so the balance sheet is not the issue; the burn rate is. The stock has already fallen 30.5% this quarter and 68.8% this year, and the consensus loss estimate was cut about 14.2% over the last three months. The Street still carries a buy rating (16 buy, 1 hold) and a $100 median price target, which now sits far above the $21.73 last close.

At the time of this announcement, GPCR was trading at $20.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $18.70 to $94.90. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

GPCR - Latest Insights

GPCR
Nov 09, 2026, 4:15 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $21.41
Real-time Price: $21.36 info
Change: -$0.050 (-0.23%) info
Market Cap: $1.551B info
GPCR
Nov 09, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $21.41
Real-time Price: $21.36 info
Change: -$0.050 (-0.23%) info
Market Cap: $1.551B info
GPCR
Sep 22, 2026, 3:15 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $36.78
Real-time Price: $21.36 info
Change: -$15.42 (-42%) info
Market Cap: $1.551B info
GPCR
Sep 08, 2026, 8:09 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $47.60
Real-time Price: $21.36 info
Change: -$26.24 (-55%) info
Market Cap: $1.551B info
GPCR
Sep 08, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $47.50
Real-time Price: $21.36 info
Change: -$26.14 (-55%) info
Market Cap: $1.551B info